Your browser doesn't support javascript.
loading
The US Biosimilar Market: Stunted Growth and Possible Reforms.
Sarpatwari, Ameet; Barenie, Rachel; Curfman, Gregory; Darrow, Jonathan J; Kesselheim, Aaron S.
Afiliación
  • Sarpatwari A; Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Barenie R; Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Curfman G; Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Clin Pharmacol Ther ; 105(1): 92-100, 2019 01.
Article en En | MEDLINE | ID: mdl-30415479

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Aprobación de Drogas / Industria Farmacéutica / Biosimilares Farmacéuticos Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Aprobación de Drogas / Industria Farmacéutica / Biosimilares Farmacéuticos Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos